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Diabetes and risk of physical disability in adults: a systematic 
review and meta-analysis
Evelyn Wong, Kathryn Backholer, Emma Gearon, Jessica Harding, Rosanne Freak-Poli, Christopher Stevenson, Anna Peeters 
Summary
Background According to previous reports, the risk of disability as a result of diabetes varies from none to double. 
Disability is an important measure of health and an estimate of the risk of disability as a result of diabetes is cr ucial 
in view of the global diabetes epidemic. We did a systematic review and meta-analysis to estimate this risk.
Methods We searched Ovid, Medline, Embase, Cochrane Library, and Cumulative Index to Nursing and Allied Health 
Literature up to Aug 8, 2012. We included studies of adults that compared the risk of disability—as measured by 
activities of daily living (ADL), instrumental activities of daily living (IADL), or mobility—in people with and without 
any type of diabetes. We excluded studies of subpopulations with speciﬁ c illnesses or of people in nursing homes. 
From the studies, we recorded population characteristics, how diabetes was diagnosed (by doctor or self-reported), 
domain and deﬁ nition of disability, and risk estimates for disability. We calculated pooled estimates by disability type 
and type of risk estimate (odds ratio [OR] or risk ratio [RR]). 
Results Our systematic review returned 3224 results, from which 26 studies were included in our meta-analyses. 
Diabetes increased the risk of mobility disability (15 studies; OR 1·71, 95% CI 1·53–1·91; RR 1·51, 95% CI 1·38–1·64), 
of IADL disability (ten studies; OR 1·65, 95% CI 1·55–1·74), and of ADL disability (16 studies; OR 1·82, 
95% CI 1·63–2·04; RR 1·82, 95% CI 1·40–2·36).
Interpretation Diabetes is associated with a strong increase in the risk of physical disability. Eﬀ orts to promote healthy 
ageing should account for this risk through prevention and management of diabetes.
Funding Monash University, Baker IDI Bright Sparks Foundation, Australian Postgraduate Award, VicHealth, 
National Health and Medical Research Council, Australian Research Council, Victorian Government.
Introduction
The prevalence of diabetes worldwide has more than 
doubled over the past three decades, with an 
estimated 347 million adults living with diabetes 
in 2008.1,2 Diabetes increases the risk of disabling 
disorders including cardiovascular disease,3 retinopathy,4 
renal failure,5 and peripheral vascular disease.4 Physical 
disability6 is a useful measure of the overall eﬀ ect of 
diabetes on health. Disability can be deﬁ ned in several 
ways, including diﬃ  culties with activities of daily living 
(ADL), diﬃ  culties with instrumental activities of daily 
living (IADL), and mobility limitations.7 In 2004, the 
worldwide direct costs of all disability to individuals was 
between 11% and 69% of income and costs to the 
governments of countries in the Organisation for 
Economic Co-operation and Development accounted for 
roughly 10% of public social spending.8
The risk of disability associated with diabetes has been 
studied previously9–12 with results ranging from no 
association to a doubling of risk. Epidemiological studies 
have varied in design, how diabetes was assessed (eg, by 
doctor or self-reported), deﬁ nition of disability, and 
length of follow-up. Few studies have analysed the 
moderating eﬀ ects of diabetes duration or glycaemic 
control and little is known of the risk of disability 
associated with measures of prediabetes—ie, impaired 
glucose tolerance or impaired fasting glucose. Although 
two reviews6,13 have qualitatively summarised the 
evidence of a relation between diabetes and disability, no 
meta-analysis has pooled estimates of this risk. Accurate 
estimation of the risk of disability associated with 
diabetes is pivotal to understanding the health needs of 
the ageing population.
We did a systematic review and meta-analysis to 
estimate the magnitude of the relation between diabetes 
and prediabetes and the risk of disability, and to analyse 
the potential moderating factors of this association, 
particularly sex, duration of diabetes, and glycaemic 
control. 
Methods
Systematic review 
The protocol for this systematic review and meta-
analysis has been published previously.14 This study was 
done in accordance with the PRISMA15 and MOOSE16 
guidelines. We searched Ovid, Medline, Embase, 
Cochrane Library, and Cumulative Index to Nursing 
and Allied Health Literature up to Aug 8, 2012 for 
reports published in English. We searched for 
“diabetes”, “glucose intolerance”, “diabet*”, “glucose 
intoleran*”, and “impaired glucose toleran*” as medical 
subject headings and keyword terms in the title, 
abstract, and text, combined with the operator “OR”. 
We included all types of diabetes irrespective of cause, 
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which includes gestational, type 1, type 2, insulin-
dependent, insulin-requiring, and insulin-depleted 
diabetes. We then combined diabetes terms with the 
operator “AND” for disability terms: “activities of daily 
living”, “disabled persons”, “mobility limitation”, as 
well as keyword terms “disabl*”, “disabiliti*”, “limit*”, 
“impair*”, “mobili*”, “ambulat*”, “activit*”, and 
“function*”. All disability terms were combined with 
the operator “OR”. The search was limited to case-
control, cohort, and cross-sectional studies, and clinical 
trials of adults older than 19 years. We also searched the 
reference lists of included studies and reviews for 
relevant reports.
Two investigators independently reviewed the retrieved 
articles in two stages; ﬁ rst assessing relevance from the 
title and abstract and if relevance was still unclear, the 
full text was read. Any disagreement about inclusion was 
referred to a third reviewer and resolved by discussion. 
We only included studies published in peer-reviewed 
journals that reported diabetes status, disability, and 
an estimate of risk for the association between diabetes 
and disability compared with no diabetes. Measures of 
disability included single and composite measures 
of disability based on ADL, IADL, or mobility. 
We excluded studies of subgroups of patients with 
speciﬁ c illnesses, or undergoing speciﬁ c medical or 
surgical procedures, and studies of nursing home 
residents. We excluded disability measures that were 
deﬁ ned by disturbances in cognitive function because 
our aim was to study physical disability. We also excluded 
studies reporting disability as a continuous measure.
When studies analysed the same population, we 
excluded the study with the weaker study design—ie, 
cohort studies were preferred to cross-sectional studies. 
If two cohort studies used the same baseline population, 
we included the study with the longer follow-up. 
Data collection 
Data from each study were independently extracted by 
two reviewers and cross-checked by EW. We recorded 
study design, baseline study year, length of follow-up, 
sample size, response rate, study characteristics, mean 
age, proportion of men, method used to ascertain diabetes 
and disability status, disability incidence, confounders, 
and eﬀ ect size with 95% CIs of the association between 
diabetes and disability. If information was missing, we 
contacted the authors. We extracted sex-speciﬁ c risk 
estimates when available. We preferentially extracted the 
risk estimates from models that adjusted for age, sex, 
education, and smoking but not for chronic diseases that 
might be part of the causal pathway.
Statistical analysis 
We pooled risk estimates according to assessment of 
disability (ADL, IADL, or mobility) and the type of risk 
estimate reported (odds ratio [OR] or risk ratio [RR]). 
Generally, studies dichotomised disability at the level of 
at least some diﬃ  culty in at least one activity. Because 
deﬁ nitions of severity of disability varied between 
studies, we analysed severity of disability according to 
the following hierarchy (least to most disabled):17 
mobility disability preceding IADL disability, and IADL 
preceding ADL disability. As a conservative approach, 
when a risk estimate was reported for a composite 
measure of disability, we included it in the analysis 
following the same hierarchy—eg, if a composite 
measure included a mobility measure, the study was 
analysed as mobility disability because mobility disability 
is ﬁ rst in the hierarchy. 
We were unable to combine ORs and RRs because we 
assumed that disability is a common outcome and 
therefore the OR and RR will not approximate each 
other.18 We subdivided the pooled ORs by study design. 
We calculated the log of the OR or RR, with standard 
errors, for all point estimates and 95% CIs using the 
generic inverse variance method. We used a random 
eﬀ ect model because we expected the data to be 
heterogeneous across studies.
We compared pooled ORs for diﬀ erent study designs 
with the test for subgroup diﬀ erences in Review Manager 
(version 5.2). If study designs did not diﬀ er signiﬁ cantly, 
we reported the ﬁ nal pooled eﬀ ect size of all studies 
combined, irrespective of design. We assessed the 
proportion of variance in pooled estimates because of 
heterogeneity by χ² and I². A p value of less than 0·1 was 
deemed signiﬁ cant. I² less than 25% was considered low 
heterogeneity, 25–75% was considered medium 
heterogeneity, and ≥75% was considered high hetero-
Figure 1: Study selection 
3224 individual articles identiﬁed 
           through systematic review
3126 excluded (title or abstract not relevant)
98 assessed for inclusion criteria
54 did not meet inclusion criteria
8 did not report compatible measure of disability
42 did not report risk association between 
disability and diabetes
4 were of speciﬁc medical subgroups or nursing 
 home residents
44 met inclusion criteria
15 excluded
      5 reported disability as a continuous measure
      3 deﬁned disability including cognitive function 
          disturbance
      7 multiple publications using the same population
26 included in meta-analysis 
   3 included in qualitative analysis
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geneity.19 We did sensitivity analyses by systematically 
excluding one study at a time and assessing any change 
in pooled eﬀ ect size. If data were available, we analysed 
the moderating eﬀ ects of sex, duration of diabetes, and 
control of diabetes on the association between diabetes 
and risk of disability. 
 Study Baseline 
year
Sample 
size
Sex Population characteristics Domain of disability studied Adjustments (model used in this 
meta-analysis)
Cross-sectional studies
Bruce (2000)40 Aboriginal Peoples 
Survey
1991 3062 Men and 
women
Metis population, Canada ADL, mobility (walk 350 m, 
ﬂ ight of stairs, one room to 
another, stand 20 min)
Age, sex, chronic health conditions 
(arthritis, hypertension, heart 
problems, and emphysema)
Chau et al 
(2011)41
Elderly Health Centres 1998–2001 66 813 Men and 
women
Elderly people from Hong Kong 
enrolled in elderly health centres
IADL Age, sex, education
Gregg et al 
(2000)42
Third National Health 
and Nutrition 
Examination Survey
1988–94 6588 Men and 
women
Non-institutionalised people 
aged 60 years and older
Mobility (walk 0·25 miles, climb 
10 steps, housework), objective 
mobility test (walking speed, 
chair stands, tandem stands)
Age, ethnic origin, education, BMI
Hiltunen et al 
(1996)43
NA 1991–92 369 Men and 
women
Non-institutionalised people 
born before 1921, in Finland
ADL, IADL, mobility (moving 
outdoors, walking indoors, walk 
400 m, stairs)
Age, sex, coronary heart disease, BMI, 
impaired glucose tolerance
Kalyani et al 
(2010)44
National Health and 
Nutrition Examination 
Survey
1999–2006 6097 Men and 
women
Non-institutionalised people 
aged 60 years and older
ADL, IADL, mobility (walk 
0·25 miles, 10 steps)
Age, sex, education, race, ethnic 
origin, smoking
Kishimoto et al 
(1998)45
NA 1994–95 7303 Men and 
women
Aged over 60 years, from ﬁ ve 
towns in Japan
ADL Age
Kriegsman et al 
(1997)46
NA 1992–93 2805 Men and 
women
Age 55–85 years from 
population registries, the 
Netherlands
Mobility (walk up or down 
15 steps, using public transport, 
cutting toenails)
Age, sex, other chronic diseases
Maggi et al 
(2004)47
The Italian Longitudinal 
Study on Aging
1992 4768 Men and 
women
Elderly Italians ADL Age, education, BMI
Malhotra et al 
(2012)48
Social Isolation, Health 
and Lifestyle Survey
2009 5000 Men and 
women
Community-dwelling 
Singaporeans aged 60 years 
and older
ADL Age, sex, ethnic origin, type of 
housing, marital status, all other 
self-reported health conditions
Martinez-Huedo 
et al (2011)49
National Health Survey, 
Spain
2000–07 7835 Men and 
women
Elderly Spanish people ADL, IADL, mobility (10 steps) Age and sex (unclear)
McLaughlin et al 
(2011)50
Australian Longitudinal 
Study on Women’s 
Health and Perth Health 
in Me Study
2008 3493 Men and 
women
National sample, Australia Mobility (climbing one or several 
ﬂ ights of stairs)
Sex, marital status, doctor-diagnosed 
chronic disorders
Nourhashemi 
et al (2001)51
Epidemiologie de 
l’ostéoporose
1992–94 7364 Women 
only
People aged over 75 years, 
France
IADL Age, cognition, vision and hearing 
disorders, fear of falling, self-rated 
health, social network, education, 
income, chronic diseases, fat mass, 
total bone mineral density
Odding et al 
(2001)52
Rotterdam Study 1989–92 3075 Men and 
women
Residents aged 55 years and 
older, the Netherlands
Mobility (climbing, walking, 
getting in and out of bed or car, 
bending, rising from chair)
Age
Patel et al 
(2006)53
Mexican Health and 
Aging Study
2001 4872 Men and 
women
Elderly Mexican people ADL Age, sex, education
Sinclair et al 
(2008)54
Case-control 403 
cases, 
403 
controls
Men and 
women
Cases: known to have diabetes, 
aged 65 and older, controls: 
non-diabetics matched for age, 
sex, and general practice, Wales
Mobility (use of aids) Mobility limitation: adjusted for age, 
hypertension, cerebrovascular 
disease, COPD, cancer, osteoarthritis, 
dementia
Tucker et al 
(2000)55
NA 1992–97 472 Men and 
women
Hispanic elderly Puerto Ricans, 
USA
ADL, IADL, mobility (walk 
0·25 miles, 10 steps)
Age
Valderrama-Gama 
et al (2002)56
NA 1994–95 772 Men and 
women
Non-institutionalised people, 
aged 65 years and older, Spain
ADL Age, sex
Wu et al (2003)57 Sacramento Area Latino 
Study on Aging
1998–99 1789 Men and 
women
Hispanic Americans aged 
60 years and older
ADL, IADL Age, sex, BMI, waist-to-hip ratio, 
household income, depression score, 
hypertension, history of stroke
Wu et al (2010)12 Social Environment and 
Biomarkers of Aging 
Study
1989 652 Men and 
women
Nationally representative 
sample aged 60 years and older, 
Taiwan
ADL, IADL, mobility (walk 
200–300 m, two to three ﬂ ights 
of stairs, getting out of bed, 
heavy housework)
Sex, age, education
(Continues on next page)
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We assessed quality according to the Newcastle-Ottawa 
Scale with highest quality assessed as: (1) longitudinal 
study design; (2) disability-free cohort at baseline; (3) 
measured glucose or physician-diagnosed diabetes; and 
(4) models adjusted for appropriate confounders 
including age, sex, smoking, and education, and 
excluding chronic diseases that might be part of the 
pathway from diabetes to disability. For studies reporting 
risk of mobility disability, objectively measured mobility 
was an additional quality criterion. Studies that met all 
quality domains were classiﬁ ed as high quality.20 
We assessed publication and selective reporting bias by 
the symmetry of the funnel plot.21 
Role of the funding source 
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Our initial search yielded 3224 articles, 98 of which had 
relevant titles and abstracts. After reading the full 
text, 44 met our inclusion criteria (ﬁ gure 1). 15 of these 
were excluded at the stage of data extraction (ﬁ gure 1).22–36 
A further three37–39 did not report CIs and were not 
available on request but the reported point estimates of 
the association between diabetes and disability were 
included in the qualitative review.
Thus, 26 studies were included in our meta-
analysis; 22 reported ORs and four reported RRs. 
Most studies were cross-sectional, nine were longitudinal, 
and one was a case-control study (table). Although the 
study of Wu and colleagues12 was longitudinal, we only 
included the results from their cross-sectional analysis of 
their baseline data because their longitudinal data 
reported change in disability status over time, not the 
risk of incident disability from diabetes.57 Length of 
follow-up in the longitudinal studies ranged from 
18 months11 to 9 years.10 
The 26 studies included 30 populations with sample 
sizes between 369 and 66 813.41,43 Study populations 
included ten from North America with ﬁ ve studies of 
speciﬁ c ethnic groups9,38,53,55,57 and one of an Indigenous 
population;40 ﬁ ve studies were done in Asia;11,12,41,45,48 nine 
in Europe;43,46,47,49,51,52,54,56,60 and one in Australia.50 Three 
study populations included only women10,51,61 and all 
studies were of populations with a mean baseline age of 
more than 55 years, with most older than 65 years. No 
 Study Baseline 
year
Sample 
size
Sex Population characteristics Domain of disability studied Adjustments (model used in this 
meta-analysis)
(Continued from previous page)
Longitudinal studies
Al Snih et al 
(2005)9
Hispanic Established 
Populations for the 
Epidemiologic Study of 
the Elderly
1993–94; 
follow-up of 
7 years
1835 Men and 
women
Mexican Americans aged 
65 years or older
ADL, mobility (stairs, walk 
0·5 miles), timed 8-foot walk
Age, sex, chronic diseases 
(hypertension, myocardial infarction, 
stroke, cancer, hip fracture), vision 
function, MMSE score, obesity at 
baseline
Gregg et al 
(2002)10
Osteoporotic Fractures 
study
1986–88; 
follow-up of 
9 years
6971 Women 
only
Community-dwelling white 
women
Mobility (walk two to three 
blocks, ten steps, housework)
Age, BMI, education, physical activity, 
oestrogen use, marital status, 
baseline functional status (level of 
reported diﬃ  culty)
Penninx et al 
(2009)58
Health, Aging, and Body 
Composition study
1997–98; 
follow-up of 
5 years
2920 Men and 
women
Well-functioning, white and 
black people aged 70–79 years, 
USA
Mobility (walk 0·25 mile, climb 
10 steps)
Age, sex, race, site, education, 
smoking, alcohol use, lung disease, 
heart disease, stroke, cancer, arthritis.
Reynolds et al 
(2003)59
Asset and Health 
Dynamics Among the 
Oldest Old and Health 
and Retirement surveys
1993, 1995, 
1998
4228 Men and 
women
70 years or older, USA ADL, IADL Age, sex, ethnic origin, family 
network, household assets, chronic 
diseases
Spiers et al 
(2005)60
Medical Research Council 
Cognitive Function and 
Ageing Study
1991–94; 
follow-up of 
2 years
10 582 Men and 
women
65 years and older, UK IADL Age, sex, chronic disorders, 
education, living status, smoking
Volpato et al 
(2003)61
Women’s Health and 
Aging Study
1991; 
follow-up of 
3 years
729 Women 
only
Patients aged 65 years and 
older with mild-moderate 
disability at baseline, USA
ADL, mobility (walk 0·25 miles, 
climb stairs), objective mobility 
test (4 m walking speed, 
chair stand, balance)
Age, race, smoking
Woo et al 
(1998)11
NA Baseline year 
not reported; 
follow-up of 
18 months
1334 Men and 
women
Aged 70 years and older, Hong 
Kong
ADL Age, sex
ADL=activities of daily living. IADL=instrumental activities of daily living. BMI=body-mass index. MMSE=mini mental state examination. COPD=chronic obstructive pulmonary disease. NA=not available.
Table: Studies included in meta-analysis
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studies deﬁ ned the type or cause of diabetes. Two 
studies10,57 further analysed the role of duration of 
diabetes in disability. Two others39,43 analysed the 
association between impaired glucose tolerance and 
disability. 
Measures of ADL included bathing, dressing, eating, 
walking across a room, transferring from a bed or chair, 
and using the toilet. Measures of IADL included using 
the phone, shopping, and using transport. Impaired 
mobility was assessed by self-reported limitations in 
walking 0·25–0·5 miles or walking up and down stairs. 
Mobility was also objectively measured by physical 
performance tests such as walking speed, chair stands, 
and balance tests.
16 studies analysed 20 populations for the association 
between diabetes and mobility disability. Of these 16, four 
objectively measured mobility.9,42,47,61 Al Snih and 
colleagues and Gregg and colleagues reported eﬀ ect sizes 
for both self-reported and objectively measured mobility 
limitation; only those relating to the objective measures 
were used in our meta-analysis. Maggi and coworkers47 
reported eﬀ ect sizes for outcomes of several physical 
performance tests but no risk association for a 
dichotomised mobility disability outcome, therefore we 
could not include their ﬁ ndings in our meta-analysis. Of 
the 15 included studies, 11 were cross-sectional, four 
longitudinal (all reported RRs), and one case-control. Two 
included women only.10,61 Maggi and coworkers47 reported 
ORs for varying severity of disability ranging from 1·39 
(95% CI 0·98–1·98) to 2·16 (95% CI 1·25–3·73) in 
women with diabetes and 1·07 (95% CI 0·72–1·58) to 
2·81 (95% CI 1·44–5·41) in men with diabetes.
Pooled ORs from cross-sectional studies showed that 
diabetes was associated with an increased odds of 
mobility disability compared with no diabetes 
(OR 1·68, 95% CI 1·50–1·88; ﬁ gure 2A). The case-control 
study reported an OR of 2·10 (95% CI 1·56–2·83). All 
together, the OR was 1·71 (95% CI 1·53–1·91). Meta-
analysis of longitudinal studies reporting RRs showed 
that people with diabetes were more likely to report 
incident mobility disability than those without diabetes 
(pooled RR 1·51, 95% CI 1·38–1·64; ﬁ gure 2B). 
Our meta-analysis of the association between diabetes 
and IADL included ten studies, all of which reported 
ORs. Pooled point estimates from cross-sectional studies 
showed an increased risk of IADL disability with diabetes 
compared with no diabetes (OR 1·67, 95% CI 1·57–1·77; 
ﬁ gure 3). Pooled estimates did not diﬀ er signiﬁ cantly 
between cross-sectional and longitudinal studies (p=0·17) 
and overall heterogeneity when cross-sectional and 
longitudinal studies were pooled was not signiﬁ cant 
(p=0·24; I²=21%). The pooled OR from combining cross-
sectional and longitudinal studies was 1·65 (95% CI 
1·55–1·74).
We analysed the risk of ADL disability associated with 
diabetes from 16 studies, representing 19 populations. 
14 studies reported eﬀ ect sizes as ORs (12 cross-sectional, 
two longitudinal) and two longitudinal studies reported 
RRs (ﬁ gure 4A). Pooled ORs from cross-sectional studies 
showed that having diabetes was associated with an 
increased odds of diﬃ  culties with ADL compared with no 
diabetes (OR 1·87; 95% CI 1·66–2·10). The pooled risk 
estimate from longitudinal studies was 1·48 (95% CI 
1·12–1·94), which is not signiﬁ cantly diﬀ erent from the 
pooled estimate from cross-sectional studies (p=0·12). All 
together, the OR was 1·82 (95% CI 1·63–2·04). Pooled 
estimates from all studies reporting RRs for ADL disability 
showed an increase in the risk of disability if the person 
had diabetes (RR 1·82; 95% CI 1·40–2·36; ﬁ gure 4B).
We report signiﬁ cant, but low heterogeneity between 
cross-sectional studies reporting the association between 
Figure 2: Association between diabetes and mobility disability
Assessed by odds ratio (A) and risk ratio (B). 
Cross-sectional studies
Bruce (2000)40
Gregg (2000; men)42
Gregg (2000; women)42
Hiltunen (1996)43
Kalyani (2010)44
Kriegsman (1997)46
Martinez-Huedo (2011)49
McLaughlin (2011)50
Odding (2001; women)52
Odding (2001; men)52
Tucker (2000)55
Wu (2010; men)12
Wu (2010; women)12
Subtotal
Heterogeneity: p=0·07; I2=39%; Z=9·06 (p<0·0001)
Case-control studies
Sinclair (2008)54
Subtotal
Z=4·87 (p<0·0001)
Total
Heterogeneity: p=0·05; I2=42%; Z=9·55 (p<0·0001)
Test for subgroup diﬀerences: χ2=1·86, df=1 (p=0·17); I2=46·2%
1·60 (1·10–2·33)
1·52 (1·03–2·24)
2·05 (1·47–2·86)
1·50 (0·80–2·81)
2·06 (1·65–2·57)
1·89 (1·33–2·69)
1·70 (1·45–1·99)
1·36 (1·19–1·55)
1·40 (1·00–1·96)
2·20 (1·50–3·23)
1·97 (1·35–2·87)
1·20 (0·60–2·40)
1·10 (0·40–3·02)
1·68 (1·50–1·88)
2·10 (1·56–2·83)
2·10 (1·56–2·83)
1·71 (1·53–1·91)
Odds ratio (95% CI)
0·1 0·2 0·5 1 2 5 10
Reduced disability risk Increased disability risk
Al Snih (2005)9
Gregg (2002)10
Penninx (2009)58
Volpato (2003)61
Total
Heterogeneity: p=0·61; I2=0%; Z=9·28 (p<0·0001)
1·46 (1·15–1·85)
1·58 (1·36–1·84)
1·44 (1·27–1·63)
1·78 (1·25–2·53)
1·51 (1·38–1·64)
Risk ratio (95% CI)
0·1 0·2 0·5 1 2 5 10
Reduced disability risk Increased disability risk
A
B
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diabetes and ADL (p=0·06; I² 39%) and mobility 
disability (p=0·07; I² 39%). Studies reporting risk of 
IADL disability did not have signiﬁ cant heterogeneity 
(I² 39%; p=0·29). 
Systematic exclusion of some individual studies from 
the analyses resulted in changes to heterogeneity and the 
eﬀ ect size in the analysis of cross-sectional studies 
addressing the association between diabetes and mobility 
disability, although we could not test whether these 
changes were signiﬁ cant (data not shown). Exclusion of 
point estimates from the study of McLaughlin and 
colleagues50 decreased the overall heterogeneity to 0% 
(p=0·56) and slightly increased the pooled OR for 
mobility disability to 1·80 (95% CI 1·65–1·96) 
from 1·71 (1·53–1·91). None of the other studies on 
mobility disability reporting ORs or RRs aﬀ ected 
heterogeneity or the pooled eﬀ ect size after exclusion 
from our analysis (data not shown). Likewise, no 
signiﬁ cant changes occurred to the heterogeneity or 
pooled estimates when any of the studies reporting risks 
of IADL disability were excluded (data not shown). 
Exclusion of the study by Kalyani and colleagues44 from 
the meta-analysis of ADL disability decreased the overall 
heterogeneity from 37% to 17% (p=0·26). The pooled 
eﬀ ect size decreased from 1·82 (95% CI 1·63–2·04) 
to 1·76 (1·59–1·94). Exclusion of the point estimate for 
men in the study by Maggi and coworkers47 also decreased 
heterogeneity to non-signiﬁ cance (I²=26%; p=0·16). 
Exclusion of the other studies of ADL that reported ORs 
did not substantially aﬀ ect heterogeneity. Only two 
studies in the meta-analysis of longitudinal studies of 
ADL disability reported RRs and heterogeneity was not 
signiﬁ cant (ﬁ gure 4).
Meta-analyses of studies that did not adjust for chronic 
diseases that might be in the pathway from diabetes to 
disability did not substantially alter the pooled eﬀ ect 
sizes. None of the studies met all of our quality criteria 
(appendix). 
We also assessed the association between diabetes and 
disability in studies that met our inclusion criteria but 
were not compatible for meta-analysis. Three studies 
reported eﬀ ect sizes without CIs. Clark and coworkers37 
reported an OR of 1·27 for mobility disability within 2 years 
(adjusted for sociodemographic, economic, and lifestyle 
factors, and multiple chronic diseases) in a population 
aged 51–61 years, though it was not signiﬁ cant (p>0·05). 
In a cross-sectional study of physical function (measured 
by the physical function component in the Medical 
Outcomes Study 36-item questionnaire) in people 
aged 60–70 years, Sayer and colleagues39 reported an OR 
of 2·73 (p<0·001) for people with diabetes compared with 
those with normal glucose tolerance. Rodriguez-Saldana 
and coworkers38 assessed the relation between diabetes 
and disability in a population in Mexico City from repeated 
surveys over 10 years. They reported RRs of 2·46 for ADL 
disability and 3·11 for IADL disability in people with 
diabetes compared with those without diabetes.
With regards to impaired glucose tolerance and risk of 
disability, Hiltunen and colleagues43 reported an OR 
of 1·12 for poorer function in people with impaired glucose 
tolerance compared with those with normal glucose 
tolerance, after adjustment for age and sex. Sayer and 
coworkers39 reported an OR of 1·62 (p=0·03). We could not 
pool these estimates because of incompatible data.
In our assessment of moderating factors, we detected 
no diﬀ erence between sexes for odds of ADL or mobility 
disability in cross-sectional studies (data not shown). Our 
data were insuﬃ  cient to analyse sex diﬀ erences in the 
relation between diabetes and disability risk from 
longitudinal studies. We were unable to analyse the roles 
of duration of diabetes or degree of glycaemic control in 
the association between diabetes and disability. Although 
two studies10,57 investigated the eﬀ ect of diabetes duration, 
the categorisations of diabetes duration were not 
comparable. All funnel plots looked symmetrical 
(appendix); however, some analyses included only a 
small number of studies. 
Discussion
This study is the ﬁ rst meta-analysis to estimate the 
magnitude of the association between diabetes and 
disability and shows a roughly 50–80% increased risk of 
disability for people with diabetes compared to people 
without diabetes. This risk accords with previous reviews 
and large longitudinal studies.6,10,13 Although ORs were 
the primary measure of risk, diﬀ erences in absolute risk 
Figure 3: Association between diabetes and instrumental activities of daily living
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oﬀ er another perspective on the implications of diabetes 
and its eﬀ ect on disability. For example, in a longitudinal 
study62 of 8344 women aged older than 65 years, the 
yearly incidence of disability in those with diabetes was 
roughly 10% compared with less than 5% in those 
without diabetes.
The major strength of our study was the inclusion of a 
large number of studies with risk estimates for diﬀ erent 
domains of disability. We showed a consistent association 
across ADL, IADL, and mobility. All but one longitudinal 
study analysed incident disability in a population free of 
disability at baseline. The consistency of our results 
between longitudinal and cross-sectional studies 
suggests little eﬀ ect of reverse causation. Furthermore, 
heterogeneity between studies was low or zero for all 
analyses. No studies met all our quality criteria, but 
Volpato and colleagues61 met all but one and reported an 
RR consistent with the pooled point estimates.
Misclassiﬁ cation of diabetes status could dilute the 
strength of association between diabetes and disability. 
Self-reported diabetes status might underestimate the 
true prevalence of diabetes, as shown in a previous large 
study in which only half of patients with diabetes knew 
their diagnosis.63 Furthermore, in longitudinal studies in 
which diabetes status is ascertained at baseline, longer 
follow-up is likely to be associated with misclassiﬁ cation 
of no diabetes, with new cases of diabetes occurring 
during follow-up. We did not analyse modiﬁ cation of risk 
by length of follow-up because of the small number of 
studies. However, the consistency of our results across 
studies with and without diabetes diagnosed by blood 
glucose analysis by a doctor suggests that this eﬀ ect is 
not a major limitation. 
No information was included about type or cause of 
diabetes—some studies might have included various 
types of diabetes. However, in elderly people, 
type 2 diabetes is predominant. Thus, we cannot establish 
whether the association between diabetes and disability 
diﬀ ers by cause of diabetes. Furthermore, the magnitude 
of associations between diabetes and disability might not 
be generalisable to all deﬁ nitions of disability, but the 
consistency of eﬀ ect sizes across the three disability types 
(ADL, IADL, and mobility) suggests that this limitation is 
not substantial.
The mechanisms by which hyperglycaemia leads to 
disability are still unclear. High concentrations of glucose 
might lead to systemic, chronic inﬂ ammation, which is 
part of a multifactorial process eventually resulting in 
disability.6,13 Some studies64,65 have also shown that 
diabetes is associated with rapid loss of skeletal muscle 
strength and quality, worsening with increased duration 
of diabetes and poor glycaemic control. The increased 
risk of disability from diabetes might be moderated by 
duration of diabetes and glycaemic control such as that 
measured by HbA1C. Wu and colleagues57 suggested that 
the longer the duration of diabetes, the greater the risk of 
disability, although this ﬁ nding was not supported by 
Gregg and coworkers.10 Poor glycaemic control and long 
duration of diabetes increase the risk of diabetic 
complications—eg, cardiovascular disease, stroke, 
peripheral vascular disease, renal disease, peripheral 
neuropathy, and retinopathy.4,66–68 All these complications 
can result in disability. No studies included in our meta-
analysis investigated the eﬀ ect of duration of diabetes or 
glycaemic control.
Some studies39,43 suggest that patients with impaired 
glucose tolerance have an increased risk of disability, 
even before progression to diabetes. Our ability to 
investigate this possibility was limited by the scarcity of 
reports analysing prediabetes. The possibility that the 
Figure 4: Association between diabetes and activities of daily living 
Assessed by odds ratio (A) and risk ratio (B). 
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risk of disability increases in a graded manner from 
impaired glucose tolerance to diabetes and might be 
moderated by duration of diabetes further emphasises 
the need for more eﬀ ective prevention of diabetes, 
particularly in middle-aged people. A large longitudinal 
study that measures fasting glucose, oral glucose 
tolerance test, HbA1c at baseline, and multiple domains 
of disability over time is needed to ﬁ ll the gaps in our 
understanding of the moderators of the association 
between diabetes, as well as the link between prediabetes 
and disability. 
As the world’s population ages, diabetes will become 
more common, increasing the need for disability-related 
health resources. Costs will be both direct (eg, for health 
services, assistive devices, nursing home costs) and 
indirect (loss of productivity both from individuals and 
their carers).
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